Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates
申请人:Mdc Max-Delbrück-Centrum Für Molekulare
Medizin Berlin - Buch
公开号:EP2368558A1
公开(公告)日:2011-09-28
The present invention relates to compounds suitable as modulators of protein misfolding and/or protein aggregation. The compounds are particularly suitable as inhibitors of amyloid aggregate formation and/or modulators of amyloid surface properties, and/or as activators of degradation or reduction of amyloid aggregates.
AZO COMPOUNDS REDUCING FORMATION AND TOXICITY OF AMYLOID BETA AGGREGATION INTERMEDIATES
申请人:Max-Delbrück-Centrum für Molekulare Medizin
公开号:EP2549999A1
公开(公告)日:2013-01-30
US8974768B2
申请人:——
公开号:US8974768B2
公开(公告)日:2015-03-10
[EN] AZO COMPOUNDS REDUCING FORMATION AND TOXICITY OF AMYLOID BETA AGGREGATION INTERMEDIATES<br/>[FR] COMPOSÉS AZO RÉDUISANT LA FORMATION ET LA TOXICITÉ DES INTERMÉDIAIRES DE L'AGRÉGATION DE BÊTA-AMYLOÏDE
申请人:MAX DELBRUECK CENTRUM
公开号:WO2011117305A1
公开(公告)日:2011-09-29
The present invention relates to compounds suitable as modulators of protein misfolding and/or protein aggregation. The compounds are particularly suitable as inhibitors of amyloid aggregate formation and/or modulators of amyloid surface properties, and/or as activators of degradation or reduction of amyloid aggregates.